Obalon Therapeutics, Inc.

Reshape Lifesciences Inc.

Neil R Drake

Mark C Brister

Andrew P Rasdal

Amy D L VandenBerg

Antonio C Llevares

Dubravka Markovic

Matthew S Lake

Josefina Nider

Nelson Quintana

Paul D Faucher

Kaushik Aroonkumar Patel

Sheldon Nelson

Daniel J Proctor

Betty Wong

Madeline Campbell

Keoni John Sundseth

Amy Dl VandenBerg

Eleanor McCarthy

Dubravka Markvoic

Kate Sapp

Amy DL Vandenberg

Amy D I Vandenberg

Amy D L Vandenberg

Antonio C Lievares

Rajan Ramaswamy

William Wistar Rhoads

Paul Daniel Faucher

Michael W Maccollum

Antonio Llevares

Paul Faucher

Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Pressure control system for intragastric device

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Intragastric device

Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.

Intragastric volume-occupying device and method for fabricating same

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.

Systems and methods for determining failure of intragastric devices

Ultrasonic systems and methods for locating and/or characterizing intragastric devices

Growing community of inventors

San Diego, CA, United States of America

Neil R Drake